| | |
PTI 04:39 PM | January 28,2009
This acquisition gives Piramal ownership of RxElite Holdings’ sales and distribution network in the US
|
|
Lison Joseph 12:19 AM | October 17,2008
Dr Reddy’s was the first Indian drug company to hive off its drug discovery related research and development activities into a separate firm
|
|
C.H. Unnikrishnan 11:55 PM | May 20,2008
It is looking to tie up for research in anti-inflammation and infectious diseases
|
|
05:22 PM | April 24,2008
NPIL group has announced a net profit of Rs333.78 crore for the financial year ended March 31, against Rs218.05 crore for the year ended March 31, 2007
|
|
livemint.com 05:26 PM | April 16,2008
Nicholas Piramal acquires Anafortan and CEFI brand groups from Khandelwal Laboratories, both of which have patented drug drug delivery systems technology
|
|
PTI 03:32 PM | March 24,2008
The pharma industry is also planning to take drugs to rural areas through post offices
|
|
C.H. Unnikrishnan 12:30 AM | March 24,2008
The network would involve a team of health workers based in villages, a tele-network connecting specialty doctors and diagnostic labs in cities and a dedicated drug distribution channel
|
|
C.H. Unnikrishnan 12:14 AM | March 12,2008
The partner, likely a multi-national pharmaceutical company with significant interest in drug discovery, will have at least 10% equity in the research unit
|
|
PTI 01:58 PM | February 15,2008
As per the agreement, both Nicholas Piramal India Ltd Research and Development and Lilly will independently carry out early clinical development of two different drug compounds
|
|
livemint.com 01:51 PM | February 07,2008
A patented product, based on the yogic principles of Pranayamam, it is the first and only medical device cleared by the US FDA for adjunctive treatment of hypertension
|
|
Our Veiw 12:01 AM | November 21,2007
The pharma industry’s strategies for the product patents regime are delivering good results
|
|
Bloomberg 11:26 PM | November 19,2007
Merck will have the option to conduct late-stage clinical trials and commercialize the drugs
FIND MORE ARTICLES ON:
Nicholas Piramal Merck
|
|
Reuters 11:57 AM | November 19,2007
While Nicholas Piramal will carry out human clinical trials, Merck has the option to advance the drug candidates to late stage clinical trials and commercialize them
|
|
C.H. Unnikrishnan 11:19 PM | October 25,2007
The leading drugmaker says contract manufacturing and diagnostics businesses helped fuel growth
|
|
C.H. Unnikrishnan 12:02 AM | September 01,2007
The spin-off is expected to save up to Rs73 crore in research costs for the company, which would add Rs3 per share to its 2007-08 profit
|
|